Sofinnova Capital XI
Share
N°01 / About
About Sofinnova Capital XI
Paris-based eleventh flagship vehicle, bringing AUM to ~€1.5B. One of Europe's largest life sciences funds, investing in 50-60 early-stage biotech and medtech startups.
N°02 / Thesis
Investment Focus
Location / RegionFrance
Funding StageSeed
Industry Focus
Biotech
Digital Health
MedTech
Investor Signals Profile
active
Sweet Spot
Clinical-stage biotech with human trial data, AI-augmented discovery, pharma validation
21 signals on Sofinnova Capital XI
10 bullish · 8 pitch do's · 3 don'ts, each with its source. From €9/month, cancel anytime.